May.2024 11
Views: 133
AUA 2024 | MacroLux Medical Unveiling Innovative Urological Solutions at the 119th AUA Annual Meeting
Introduction
From May 3rd to 6th, 2024, the 119th Annual Meeting of the American Urological Association (AUA) was held in San Antonio, Texas, USA, attracting top experts in the field of urology from around the world to showcase the latest advancements in urological surgery.
Details


As the largest and most influential academic conference in urology globally, the AUA Annual Meeting presented an unprecedented feast of groundbreaking research, novel guidelines, and the latest developments in urological medicine. Over 10,000 professionals from more than 100 countries and regions gathered together to explore the vibrant dynamics of the industry. Founded in 1902, the American Urological Association (AUA) is one of the leading organizations in urology worldwide, with over 25,000 members representing 138 countries and regions.

 

Through education, research, and healthcare policy development, AUA collaborates closely with urology experts worldwide to promote the latest scientific research and clinical treatment in the field of urology, ensuring that patients worldwide receive the highest level of medical care. AUA publishes several important publications, including The Journal of Urology® (JU), Urology Practice® (UPJ), JU Open Plus (JUOP), and AUANews.

 

The AUA 2024 Annual Meeting held in San Antonio featured the second edition of the Innovation Nexus, which became one of the highlights. As the only incubator dedicated to urology, the Innovation Nexus provided a powerful platform for driving discoveries, improving patient care, and saving lives in the field of urology. The Innovation Nexus not only focuses on cultivating leadership and business acumen in urologists but also provides more guidance opportunities for students and interns through the AUA Urology Future program, ensuring the excellent inheritance of urology.

 

David F. Penson, MD, MPH, the Secretary of AUA, also launched a series of innovative projects, including "P2s: Paradigm-shifting, Practice-changing Clinical Trials in Urology." "These highly anticipated research projects are influencing clinical practices in unprecedented ways, including randomized clinical trials of new drugs and surgical methods that will truly change how we practice urology."

 

During the exhibition, MacroLux Medical showcased a range of urological solutions, including CoralView® Single-Use Digital Flexible Ureteroscope, BubbleView® Single-Use Digital Flexible Cystoscope, and ViewHub® S13 Video Processor.

 





These products received high praise from dozens of urology experts in attendance, particularly for their clear image display and excellent maneuverability. These solutions provide doctors with outstanding performance and reliable tools to assist them in precise diagnosis and treatment. By using MacroLux Medical's disposable ureteroscope and disposable cystoscope products, doctors can obtain clear endoscopic images, enabling them to more accurately assess the condition and develop treatment plans. The outstanding performance of these solutions has generated high expectations for their widespread application in the US market among attending experts.

 

In the future, MacroLux Medical will continue to focus on the field of disposable electronic endoscopes, dedicating itself to research, development, and promotion of new medical technologies, providing original Chinese contributions to the advancement of urological science, and ensuring better care for every life. The success of the exhibition also inspires us to constantly pursue excellence and bring more innovations and breakthroughs to the medical industry.